Rebecca Halperin

Title: The Innovative Contributions of Rebecca Halperin

Introduction

Rebecca Halperin is a prominent inventor based in Phoenix, Arizona. She has made significant strides in the field of genomics, particularly in the detection of genetic variants in tumors. Her work is crucial for advancing cancer research and improving diagnostic methods.

Latest Patents

Rebecca Halperin holds a patent for "Methods of detecting somatic and germline variants in impure tumors." This innovative system considers allele fraction shifts as a function of copy number and clonal heterogeneity. It leverages differences between allele frequencies to differentiate between somatic and normal variants in impure tumor samples. The system explicitly models allelic copy number and clonal sample fractions, allowing for a comprehensive examination of how these factors impact the detection of somatic variants. By modeling copy number alterations, the system can also affect the allele frequencies of both somatic and germline variants, providing a more accurate understanding of tumor content.

Career Highlights

Rebecca is affiliated with the Translational Genomics Research Institute, where she contributes her expertise in genomics and cancer research. Her work has been instrumental in developing methods that enhance the accuracy of genetic variant detection in tumors.

Collaborations

Rebecca collaborates with various professionals in her field, including her coworker David Craig. Their combined efforts aim to push the boundaries of genomic research and improve patient outcomes.

Conclusion

Rebecca Halperin's innovative contributions to the field of genomics exemplify the importance of research in understanding cancer. Her patent and work at the Translational Genomics Research Institute highlight her commitment to advancing medical science.